Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
International Journal of Cancer|February 14, 2013
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide moleculeFrançoise Degoul, Michèle Borel, Nathalie Jacquemot, et al.Gut Microbes|January 3, 2024
Pasteurized <i>akkermansia muciniphila</i> improves irritable bowel syndrome-like symptoms and related behavioral disorders in miceMaëva Meynier, Valentine Daugey, Geoffroy Mallaret, et al.Scientific Reports|June 6, 2020
Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected ratsManon Defaye, Céline Nourrisson, Elodie Baudu, et al.Journal of Medicinal Chemistry|March 23, 2011
Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracersAurélie Maisonial, Bertrand Kuhnast, Janine Papon, et al.Clinical & Experimental Metastasis|July 7, 2014
Annexin A1 in primary tumors promotes melanoma disseminationZied Boudhraa, Fabien Rondepierre, Lemlih Ouchchane, et al.Gut Microbes|January 29, 2022
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptomsMaëva Meynier, Elodie Baudu, Nathalie Rolhion, et al.Oncotarget|April 21, 2017
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancerAurelie Maisonial-Besset, Tiffany Witkowski, Isabelle Navarro-Teulon, et al.Gut Microbes|February 28, 2024
The colibactin-producing <i>Escherichia coli</i> alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistanceNilmara de Oliveira Alves, Guillaume Dalmasso, Darja Nikitina, et al.Cell|July 2, 2021
Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthyVivien Béziat, Franck Rapaport, Jiafen Hu, et al.Pageof 6